Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04786964
Title Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab (CK-301) in First Line Metastatic Non-squamous Non-Small Cell Lung Cancer (CONTERNO)
Acronym CONTERNO
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Checkpoint Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NZL

Facility Status City State Zip Country Details
Research Site Vitória Brazil Details
Research Site Tbilisi Georgia Details
Research Site Kota Bharu Malaysia Details
Research Site Wellington New Zealand Details
Research Site Lima Peru Details
Research Site Arkhangel'sk Russian Federation Details
Research Site Chelyabinsk Russian Federation Details
Research Site Kaliningrad Russian Federation Details
Research Site Kazan Russian Federation Details
Research Site Kursk Russian Federation Details
Research Site Kuzmolovskiy Russian Federation Details
Research Site Moscow Russian Federation Details
Research Site Nizhny Novgorod Russian Federation Details
Research Site Novosibirsk Russian Federation Details
Research Site Omsk Russian Federation Details
Research Site Saint Petersburg Russian Federation Details
Research Site Samara Russian Federation Details
Research Site Sochi Russian Federation Details
Research Site Tomsk Russian Federation Details
Research Site Volgograd Russian Federation Details
Research Site Pretoria South Africa Details
Research Site Chiang Mai Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field